NCT04201899

Brief Summary

The point prevalence survey aims at defining the until now unknown real prevalence of hypophosphatemia (defined as blood phosphate value \< 0.8 mmol/l) in international critical care settings

Trial Health

90
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
890

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Mar 2020

Shorter than P25 for all trials

Geographic Reach
3 countries

4 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 14, 2019

Completed
3 days until next milestone

First Posted

Study publicly available on registry

December 17, 2019

Completed
3 months until next milestone

Study Start

First participant enrolled

March 9, 2020

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 31, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 31, 2020

Completed
Last Updated

February 2, 2021

Status Verified

January 1, 2021

Enrollment Period

5 months

First QC Date

December 14, 2019

Last Update Submit

January 31, 2021

Conditions

Critically Ill

Keywords

Phosphate

Outcome Measures

Primary Outcomes (1)

  • Prevalence of hypophosphatemia

    Blood value \< 0.8 mmol/l

    1 day

Interventions

No intervention - pure observationDIETARY_SUPPLEMENT

Phosphate administration (yes or no)

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Critically ill patients: adults and children

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (4)

Tartu University Hospital

Tartu, 50407, Estonia

Location

Hôpital Pasteur 2

Nice, 06000, France

Location

Lausanne University Hospital

Lausanne, Canton of Vaud, 1011, Switzerland

Location

Hôpital de Nyon

Nyon, 1260, Switzerland

Location

Related Publications (1)

  • Berger MM, Appelberg O, Reintam-Blaser A, Ichai C, Joannes-Boyau O, Casaer M, Schaller SJ, Gunst J, Starkopf J; ESICM-MEN section. Prevalence of hypophosphatemia in the ICU - Results of an international one-day point prevalence survey. Clin Nutr. 2021 May;40(5):3615-3621. doi: 10.1016/j.clnu.2020.12.017. Epub 2020 Dec 29.

    PMID: 33454128DERIVED

MeSH Terms

Conditions

Critical Illness

Condition Hierarchy (Ancestors)

Disease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Mette M BERGER, MD PhD

    Lausanne University Hospital, Lausanne, Switzerland

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
1 Day
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

December 14, 2019

First Posted

December 17, 2019

Study Start

March 9, 2020

Primary Completion

July 31, 2020

Study Completion

July 31, 2020

Last Updated

February 2, 2021

Record last verified: 2021-01

Data Sharing

IPD Sharing
Will not share

Data will be collected in central REDCap database. No individual patient data will be made available

Locations

CH(2)ES(1)FR(1)